Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
about
Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery.Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ERα.Glucose Metabolism in the Progression of Prostate Cancer.Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells.The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy.Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesisBlocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cellsCancer stemness and progression: mitochondria on the stage.Metformin targets histone acetylation in cancer-prone epithelial cells.Mevalonate Metabolism in Immuno-Oncology.PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.Signaling Pathways Regulating Redox Balance in Cancer Metabolism.PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer.Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2
P2860
Q36023978-64E35509-888A-4E40-9CA9-92440A76FD4AQ37702066-92238907-DC02-4AC7-AFA2-E9C38A0F6ABDQ37713095-D22B4CC4-B81A-462D-BF7B-32B6BB0B5678Q38655417-3B03EDF9-9B77-4ABB-AE3F-2343453A59B9Q38662384-741C0053-9910-42EC-97EE-C584AA579926Q38728567-172FA81B-83BC-4573-8887-F73C54E1692CQ38742768-93E18641-E9F9-4AE9-AD8F-A0DDBC557DFDQ39167169-C3357C0F-6719-4408-A310-031811CAB529Q39205930-0BAC50E4-A3A7-4DC8-9BA1-38BD0F157084Q40221658-DA20DB56-38E3-44CA-9BED-5DD100B21441Q41339597-046A8C8E-1660-4CB2-8750-042FEDAD50A8Q41561467-010B043F-4497-40DB-972D-DFA5702872DFQ41809872-04E5DEE2-226B-40DB-9C94-8ED53D2E7AE9Q42250126-65133DAA-1033-44CE-9E94-EC75EB6AEC38Q42552304-9B10D5E9-78D4-402C-9418-797969C5149EQ42983569-1E3A1CB1-32EC-4881-AA3A-B96D35023679Q47105437-C14DC61C-49B0-447C-A47C-AA739FCBA208Q51007532-BABA53E0-33F0-4E77-B4BF-FA34285C0EAEQ54979494-BD3EBF79-3CCC-4CF7-BCEC-A796E43A008CQ55355817-E3BC7E1C-EA75-439F-B7A6-B48F986E0842Q58554069-9207DAC2-1DA5-49E4-BBA7-AC25D4E6E248
P2860
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting stromal-induced pyru ...... tate cancer metastatic spread.
@en
type
label
Targeting stromal-induced pyru ...... tate cancer metastatic spread.
@en
prefLabel
Targeting stromal-induced pyru ...... tate cancer metastatic spread.
@en
P2093
P2860
P50
P356
P1433
P1476
Targeting stromal-induced pyru ...... state cancer metastatic spread
@en
P2093
Barbara Richichi
Francesca Bianchini
Maria Letizia Taddei
Maura Calvani
Nicholas Wong
Paola Chiarugi
P2860
P304
24061-24074
P356
10.18632/ONCOTARGET.4448
P407
P577
2015-09-01T00:00:00Z